University of Cambridge > > Cambridge Neuroscience Seminars > Intrabodies for Huntington's and Parkinson's disease therapeutics

Intrabodies for Huntington's and Parkinson's disease therapeutics

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact ejjd2.

Accumulation of misfolded proteins characterizes several important neurodegenerative diseases, including Huntington’s and Parkinson’s. The specificity and engineering potential of antibody fragments offers multifunctional approaches to modify the toxic effects of such proteins. By targeting the proteins intracellularly, intervention can occur at the earliest stage in a pathogenic cascade. Huntington’s offers particularly robust models and the can serve as a paradigm for related disorders.

This talk is part of the Cambridge Neuroscience Seminars series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity